Alignment Healthcare (ALHC) CEO John Kao Sells 298,000 Shares

What Happened
John E. Kao, CEO of Alignment Healthcare (ALHC), disposed of 298,000 shares in open-market sales on August 10, 2026, generating proceeds of $4,136,776. The reported weighted-average sale price was $13.88 per share; individual trades ranged from $13.62 to $14.30. The sales were executed under a Rule 10b5-1 trading plan adopted November 21, 2025.

Key Details

• Transaction type: Sale (Code S) — open-market/private sale on 2026-08-10.
• Shares sold: 298,000; weighted-average price: $13.88; total proceeds: $4,136,776.
• Price range: $13.62 to $14.30 (reporting person will provide per-price breakdown on request).
• 10b5-1 plan adoption date: 11/21/2025 (footnote F1).
• Shares represent securities held by the JEK Trust (dated Feb 8, 2021), of which Mr. Kao is trustee (footnote F3).
• Filing date matches transaction date (2026-08-10), indicating a timely Form 4 filing based on provided data.
• Shares owned after the transaction were not specified in the provided excerpt.

Context
Sales executed under an established 10b5-1 plan are typically prearranged and can be routine liquidity events rather than signals of new company-specific information. For retail investors, purchases tend to be more informative about insider confidence; sales alone do not necessarily imply negative outlook. The trust ownership note indicates these shares were held in a trust for which Mr. Kao is trustee, not necessarily direct beneficial ownership.